Log In
BCIQ
Print this Print this
 

LEDGF1-326, OCU100

  Manage Alerts
Collapse Summary General Information
Company Ocugen Inc.
DescriptionRecombinant PC4 and SFRS1-interacting protein (PSIP1; LEDGF; p75; LEDGF/p75) fragment 1-326
Molecular Target PC4 and SFRS1-interacting protein (PSIP1) (LEDGF) (p75) (LEDGF/p75)
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationRetinitis
Indication DetailsTreat retinitis pigmentosa
Regulatory Designation U.S. - Orphan Drug (Treat retinitis pigmentosa)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/05/2014

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today